Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 196Triple Negative Breast Neoplasms 26Neoplasm Metastasis 18Breast Neoplasms, Male 13Ovarian Neoplasms 9Inflammatory Breast Neoplasms 9Pancreatic Neoplasms 8Neoplasms 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Stomach Neoplasms 5Prostatic Neoplasms 4Lung Neoplasms 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Multiple Myeloma 2Lymphedema 2Hematologic Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Brain Neoplasms 2Uterine Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1

Interventions

Psychiatric Rehabilitation 1Neoadjuvant Therapy 1Mammaplasty 1Hyperbaric Oxygenation 1Fluorouracil 1Fibrin Tissue Adhesive 1Epirubicin 1Docetaxel 1Dexamethasone 1Cyclophosphamide 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Complications × Bevacizumab × Breast × Clear all
NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡